Significant differences were detected in the pre-ERC levels of GGT, ALT, and CA19-9 between the poor jaundice-reducing group and the good jaundice-reducing group (260.0 vs. 479.5 U/L, 55.0 vs. The gene discussed is GPT; the disease is Jaundice.